Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense
Published
Despite scant evidence that it works, the drug, Aduhelm, is predicted to generate billions of dollars in revenue, much of it from Medicare.
Full ArticlePublished
Despite scant evidence that it works, the drug, Aduhelm, is predicted to generate billions of dollars in revenue, much of it from Medicare.
Full ArticleDespite scant evidence that it works, the drug, Aduhelm, is predicted to generate billions of dollars in revenue, much of it from..